XBiotech Announces Dr. Alice Gottlieb to Chair Upcoming Phase 2 Study of Bermekimab in Hidradenitis Suppurativa

Press/Media

Period	25 Jun 2019

Media coverage

Title	XBiotech Announces Dr. Alice Gottlieb to Chair Upcoming Phase 2 Study of Bermekimab in Hidradenitis Suppurativa
Media name/outlet	USA Life Sciences Database
Country/Territory	Switzerland
Date	25/06/19
URL	www.usalifesciences.com/us/portal/news_details.php?news_id=17473051k$Sn5vl7Ufw3pnI&page_id=?next=1
Persons	Alice Gottlieb